HAEMATOLOGY CONFERENCE

6 February 2018

5.75 CME Points

Za’abeel Hall 6, Conference Room 1

Overview

There have been several new developments in the field of haematology and oncology. Focusing on the lab testing and interpretation of treatment of blood-related diseases, the CME- accredited Haematology conference provides an opportunity to the delegates to discuss the emerging therapeutic options and recognise the factors that affect the diagnosis, staging, and prognosis of patient’s treatments.

Key topics:

  • Quality assurance in haematology
  • Revised 2016 WHO classification of Lymphoid Neoplasms
  • Minimal Residual disease in Myeloma
  • Transfusion support for transplant patients
  • Future of transfusion medicine
     

Benefits of attending:

  • Evaluate quality improvement in haematology practices
  • Discuss updates on WHO classification
  • Identify pitfalls and their impact on laboratory results and interpretation
  • Determine challenges in quality assurance in haematology
  • Review approaches in screening results in the day to day clinical practice

Chair: Dr Rania Medhat Seliem, Consultant Hematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai, UAE     
Activity Director: Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA

 

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics | Beckman Coulter | Siemens Healthineers

Supported by:

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics
Beckman Coulter
Siemens Healthineers

09:20

Opening remarks by the chairs

Dr Rania Medhat Seliem, Consultant Hematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai Health Authority, Dubai, UAE

Dr Eiman Al Zaabi, Director, Dept. of Clinical Pathology, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, UAE

Session 1: Clinical Haematology

Moderator: Dr Eiman Al Zaabi, Director, Dept. of Clinical Pathology, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, UAE

09:30

Problems in the coagulation laboratory: An approach to problem solving and troubleshooting

Dr Allam Shawwa, Associate Professor, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

10:00

The clinical use of RET-He in the differential diagnosis of anaemia

Dr Margreet Schoorl, Manager, Department for ClinicalChemistry, Haematology and Immunology, Northwest Clinics,Helder, The Netherlands

10:30

Platelet function disorders: Laboratory testing update

Dr Allam Shawwa, Associate Professor, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

11:00 Coffee Break


Session 2: NEOPLASTIC HAEMATOLOGY

Moderator: Dr Rania Medhat Seliem, ConsultantHematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai  Health Authority, Dubai, UAE

11:30

Gray zone between Burkitt and diffuse large B-cell lymphoma

Dr Eric D. Hsi, Section Head, Hematopathology; Chair, Department of Laboratory Medicine Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA

12:00

Myeloid leukemia in down syndrome

Dr Ziad Peerwani, Consultant Physician, Anatomic Pathology & Cytopathology - Medical Affairs, Tawam Hospital, Al Ain, UAE

12:30

Monoclonal B-cell lymphocytosis, detection and significance

Dr Eric D. Hsi, Section Head, Hematopathology; Chair, Department of Laboratory Medicine

Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA

13:00 Lunch Break


Session 3: QUALITY IMPROVEMENT IN CLINICAL HAEMATOLOGY PRACTICES

Moderator: Dr Eiman Al Zaabi, Director, Dept. of Clinical Pathology, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, UAE

14:00

Quality assurance for platelet function testing

Dr Kandice Kottke-Marchant, Chair- Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA

14:45

Pre-analytical challenges and quality assurance in coagulation testing

Dr Jay Murthy, Technical Director, National Reference Laboratory, Abu Dhabi, UAE

15:30 Coffee Break


Session 4: ACCREDITATION STANDARDS AND EXPERIENCES

16:00

CAP/ISO15289 similarities and differences

Dr Najeeba Mohammed Baroud, Senior Quality Supervisor, Sheikh Khalifa Medical City, Abu Dhabi, UAE

16:30

Panel Discussion: Sharing of accreditation experiences

17:00 End of conference

Supported by:

ACTIVITY DIRECTORS:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA


PLANNING COMMITTEE:

Dr Rania Medhat Seliem, Consultant Hematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai Health Authority, Dubai, UAE

Dr Eiman Al Zaabi, Director, Dept of Clinical Pathology, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, UAE


SPEAKER FACULTY:

Dr Allam Shawwa, Associate Professor, Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada

Dr Eric D. Hsi, Section Head, Hematopathology; Chair, Department of Laboratory Medicine Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA

Dr Jay Murthy, Technical Director, National Reference Laboratory, Abu Dhabi, UAE

Dr Kandice Kottke-Marchant, Chair- Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA

Dr Margreet Schoorl, Manager, Departmentfor Clinical Chemistry, Haematology and Immunology, Northwest Clinics, Helder, The Netherlands

Dr Najeeba Mohammed Baroud, Senior Quality Supervisor, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Dr Ziad Peerwani, Consultant Physician, Anatomic Pathology & Cytopathology - Medical Affairs, Tawam Hospital, Al Ain, UAE

Supported by: